Talk:Alteplase: Difference between revisions
No edit summary |
No edit summary |
||
Line 36: | Line 36: | ||
[[User:Rin1725|Rin1725]] ([[User talk:Rin1725|talk]]) 14:22, 27 October 2020 (UTC)Rin1725 |
[[User:Rin1725|Rin1725]] ([[User talk:Rin1725|talk]]) 14:22, 27 October 2020 (UTC)Rin1725 |
||
→Welcome, I would really appreciate your input on the adverse effects section as well. Bleeding is obvious, but there seems to be very little secondary literature on any other adverse effects. Additionally, I am looking to add some images, but I am having trouble finding useful images without CC. Any thoughts[[User:Mitchell.mcelroy|Mitchell.mcelroy]] ([[User talk:Mitchell.mcelroy|talk]]) 22:50, 27 October 2020 (UTC) |
→Welcome, I would really appreciate your input on the adverse effects section as well. Bleeding is obvious, but there seems to be very little secondary literature on any other adverse effects. Additionally, I am looking to add some images, but I am having trouble finding useful images without CC. Any thoughts[[User:Mitchell.mcelroy|Mitchell.mcelroy]] ([[User talk:Mitchell.mcelroy|talk]]) 22:50, 27 October 2020 (UTC) |
||
→→I see that you have ordered contraindications into its own category. The reason I had those apart for each medical use was because the contraindications are in fact different for each medical use. Let me know what you think. |
→→I see that you have ordered contraindications into its own category. The reason I had those apart for each medical use was because the contraindications are in fact different for each medical use. Let me know what you think.[[Special:Contributions/2001:48F8:9:14F2:511C:4565:F971:FF3D|2001:48F8:9:14F2:511C:4565:F971:FF3D]] ([[User talk:2001:48F8:9:14F2:511C:4565:F971:FF3D|talk]]) 18:33, 30 October 2020 (UTC) |
Revision as of 18:33, 30 October 2020
This article was the subject of a Wiki Education Foundation-supported course assignment, between 15 September 2020 and 7 December 2020. Further details are available on the course page. Student editor(s): Rin1725, Abbysaunders, Igarnish (article contribs).
Pharmacology Stub‑class High‑importance | ||||||||||
|
Medicine Start‑class High‑importance | ||||||||||
|
This article was the subject of a Wiki Education Foundation-supported course assignment, between 19 October 2020 and 13 November 2020. Further details are available on the course page. Student editor(s): Mitchell.mcelroy (article contribs).
Planned work October 2020
UCF COM Wiki Project Medicine Workplan
Hello, I will be working on this article for about the next month.
My Goals are.
- Introduce a Indication-Contraindication section.
- Make a more robust discussion over the History of the use of this medicine.
- More organization to the Adverse Effects profile of the drug in other patient groups.
- Once these are fixed, I may go more into details of the mechanism of action and pharmacology
--Mitchell.mcelroy (talk) 20:22, 22 October 2020 (UTC)
- User:Mitchell.mcelroy - welcome! I encourage you to look through the "Manual of Style" for medicine related articles, specifically this section regarding the typical section headings for an article. I think your work will be great and please feel free to ping myself or anyone else if you have any questions regarding guidelines on Wikipedia. You can ping someone by pasting
{{ping|username}}
followed by your comment and then ~~~~ to sign your post. -bɜ:ʳkənhɪmez (User/say hi!) 20:34, 22 October 2020 (UTC)
- User:Mitchell.mcelroy Looking forward to improving this page together as Wiki Project students, feel free to reach out to us @Abbysaunders:@Igarnish:@Rin1725: for any questions or concerns! Rin1725 (talk) 14:34, 27 October 2020 (UTC)Rin1725
Deleted "Alteplase is a manufactured form of tissue plasminogen activator. It works by converting plasminogen to plasmin in a blood clot." — Preceding unsigned comment added by Mitchell.mcelroy (talk • contribs) 20:54, 26 October 2020 (UTC)
Wiki Project 2020
Hi! We are students from McMaster University, and we aim to help edit and expand the Wikipedia Alteplase page during the next few months.
Goals:
- Expand on the Medical Uses section by creating subsections dedicated to STEMI, acute ischemic stroke, pulmonary embolism, and blocked catheters, as well as subsections on side effects and contraindications
- Expand on the Society and Culture section, add information on how Alteplase was recently included in the WHO Model List of Essential Medicine
- Create a new Safety section by referring to recent review articles on Alteplase’s safety and efficacy for each indication
Our Team: @Abbysaunders: @Igarnish: @Rin1725:
Rin1725 (talk) 14:22, 27 October 2020 (UTC)Rin1725
→Welcome, I would really appreciate your input on the adverse effects section as well. Bleeding is obvious, but there seems to be very little secondary literature on any other adverse effects. Additionally, I am looking to add some images, but I am having trouble finding useful images without CC. Any thoughtsMitchell.mcelroy (talk) 22:50, 27 October 2020 (UTC)
→→I see that you have ordered contraindications into its own category. The reason I had those apart for each medical use was because the contraindications are in fact different for each medical use. Let me know what you think.2001:48F8:9:14F2:511C:4565:F971:FF3D (talk) 18:33, 30 October 2020 (UTC)